(5R,7R,8S,9S,10R)-3-(3,5-Dimethoxyphenyl)-1,6-dioxa-7-(hydroxymethyl)-2-azaspiro[4.5]dec-2-ene-8,9,10-triol

ID: ALA3764911

Chembl Id: CHEMBL3764911

PubChem CID: 127025648

Max Phase: Preclinical

Molecular Formula: C16H21NO8

Molecular Weight: 355.34

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  COc1cc(OC)cc(C2=NO[C@@]3(C2)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c1

Standard InChI:  InChI=1S/C16H21NO8/c1-22-9-3-8(4-10(5-9)23-2)11-6-16(25-17-11)15(21)14(20)13(19)12(7-18)24-16/h3-5,12-15,18-21H,6-7H2,1-2H3/t12-,13-,14+,15-,16-/m1/s1

Standard InChI Key:  WFOMIPBJAVASTI-IBEHDNSVSA-N

Alternative Forms

1. Parent:

   

   ALA3764911

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 355.34

Molecular Weight (Monoisotopic): 355.1267

AlogP: -1.00

#Rotatable Bonds: 4

Polar Surface Area: 130.20

Molecular Species: NEUTRAL

HBA: 9

HBD: 4

#RO5 Violations: 0

HBA (Lipinski): 9

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 12.05

CX Basic pKa: 2.01

CX LogP: -0.64

CX LogD: -0.64

Aromatic Rings: 1

Heavy Atoms: 25

QED Weighted: 0.54

Np Likeness Score: 1.41

References

1. Goyard D, Kónya B, Chajistamatiou AS, Chrysina ED, Leroy J, Balzarin S, Tournier M, Tousch D, Petit P, Duret C, Maurel P, Somsák L, Docsa T, Gergely P, Praly JP, Azay-Milhau J, Vidal S..  (2016)  Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition.,  108  [PMID:26708111] [10.1016/j.ejmech.2015.12.004]

Source

Source(1):

• Scientific Literature